Diabetes treatment


WDC15 Basic and Clinical Stream to offer extensive coverage on treatment advances

Since the stunning discovery in Toronto in 1922 that type 1 diabetes arises from a deficiency of insulin, a novel hormone produced in the pancreas, the management of diabetes has been firmly grounded in scientific advances that continue to shape our understanding of the pathophysiology and guide our choices in selecting optimal therapies for type 1 and type 2 diabetes.

Continuous Glucose Monitoring (CGM) in resource limited settings

Continuous Glucose Monitoring (CGM) is a relatively new technology which has the potential to assist people living with type 1 or type 2 diabetes and treated with insulin to achieve the goal of optimum control of blood glucose.

In the spirit of patient centeredness

Angus Forbes

Are the latest treatment innovations enough for people living with diabetes in the 21st century? How can the medical profession utilise current technologies and treatment innovations without losing touch with patient values and the power of compassion and insight?

The role of diabetes technology in children and youth: getting connected for better control

Francine R. Kaufman

Debate - Insulin pump therapy: a matter of choice?

Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes


Joyce P. Yi-Frazier and colleagues for the SEARCH for Diabetes in Youth Study Group

Diversity, debate and new directions

Targeting today’s most contemporary issues, the Basic and Clinical Science Stream may provide this year’s Congress with the biggest buzz, especially in areas of obesity, diabetes complications and new treatment strategies. A range of provocative topics including debates about driving type 2 diabetes prevention and bariatric surgery will be presented. Noteworthy speakers will discuss new treatment options for both types of diabetes and present the latest results of clinical trials. Mark Cooper and Sophia Zoungas talk about the exciting programme this year.

Gestational diabetes – an update from India

In recent decades, more women of a reproductive age have diabetes, and more pregnancies are complicated by pre-existing diabetes especially in low- and middle-income countries (LMICs). Also of concern is gestational diabetes mellitus (GDM) - the type of diabetes that is first recognized during pregnancy and affects up to 15% of women worldwide.

Guidelines for type 2 diabetes - designed to help newly diagnosed children and adolescents

The prevalence of childhood obesity has increased dramatically worldwide with potentially dire consequences to the health of children and to their future. Drs. Warren Lee of Singapore and Stuart Brink of the USA introduce the new American Academy of Pediatrics guidelines for newly diagnosed type 2 diabetes in children and adolescents, explaining how the evidence-based recommendations are essential for all physicians involved in the care of children.

New treatments for type 2 diabetes – what is on the horizon?

Worldwide, more than half the people with type 2 diabetes have blood glucose concentrations that are too high, leading to a greater risk of complications. This is partly because many existing treatments have limitations.